NAD+ vs Glutathione: Differences and Human Research
Published · Page updated
Bookmark this page
Save this article in your browser so you can find it again:
- Computer: Press Ctrl+D (Windows) or ⌘+D (Mac).
- iPhone or iPad: In Safari, tap Share, then Add Bookmark.
- Android: In Chrome, open the menu and tap the star.
Other browsers may use a different menu.
NAD+ and glutathione are different molecules with different biochemical roles. The selected human studies below do not establish that one is a better treatment, supplement or research product than the other. NAD+ is a coenzyme involved in redox reactions and other cellular processes. Glutathione is a tripeptide involved in cellular redox defense. Sharing a role in redox biology does not make them interchangeable.
Publisher disclosure: Bio Research LLC operates Bio Peptides Labs and sells research materials. This commercially interested, AI-assisted article is not an independent scientific review. Source-access limits appear below.

NAD+ and glutathione are not the same kind of molecule
Question | NAD-related system | Glutathione system |
|---|---|---|
What forms are being discussed? | NAD+ and its reduced form, NADH | Reduced glutathione, GSH, and oxidized glutathione, GSSG |
What does a related abbreviation mean? | NADP+ and NADPH are a distinct phosphorylated pair | GSH and GSSG identify different redox states |
Why can a blood result be hard to interpret? | The form, sample compartment and assay affect the meaning | Total glutathione and the balance between forms answer different questions |
A 2026 study of blood NAD and glutathione measurements describes assays for these six metabolites. Its healthy participants ranged from 18 to 70, and the authors reported no age-related change in these blood measurements in that population. That result should not be generalized to every tissue or every aging process. The study is not a head-to-head trial of NAD+ versus glutathione products.
Our NAD+ versus NADH guide and GSH versus GSSG guide explain why the specific form matters.
What selected human studies actually tested
Study | Design and population | Reported finding | What it does not establish |
|---|---|---|---|
Eleven men: eight received intravenous NAD+ and three saline; measurements over eight hours | Changes in blood and urine NAD-related metabolites; no adverse events observed during the six-hour infusion in the small NAD+ group | A longevity or sustained-energy benefit, long-term safety, or superiority to glutathione | |
Randomized, placebo-controlled oral glutathione study in 54 nonsmoking adults over six months | Increases in glutathione measurements in several sampled compartments | A direct comparison with NAD+, or proof of a broad clinical benefit | |
Randomized, placebo-controlled oral glutathione study in 40 healthy volunteers over four weeks; 39 completed | No significant improvement in the measured glutathione and oxidative-stress markers | That every glutathione formulation, population or longer study would have the same result |
The two oral glutathione studies differ in duration and other design details. Their findings should be compared with those differences visible, rather than collapsed into “glutathione works” or “glutathione does nothing.” Neither was designed to select a winner against NAD+.
Why a biochemical change is not automatically a health benefit
A laboratory endpoint can establish that a measurement changed. A useful clinical claim needs an outcome that matters to participants, an appropriate comparison and enough follow-up. Those requirements remain important even when a molecule has a familiar role in normal biology.
For example, the NAD+ pilot followed metabolites during and shortly after a defined infusion. That is a different question from whether people feel better for months, develop fewer diseases or live longer. The size and duration also limit what can be concluded from the absence of observed adverse events.
An additional distinction is the material being studied. Evidence for NAD precursors cannot automatically be assigned to NAD+ itself. The NAD+, NMN and NR comparison addresses that separate search topic.
Questions about NAD+ versus glutathione
Is NAD+ better than glutathione for aging?
The selected sources do not establish a general winner. Normal biochemical functions, blood-marker changes and claims about aging outcomes are different levels of evidence. A valid comparison would specify the intervention, population and outcome before comparing results.
Can the two be combined based on their biochemical connection?
A connection between pathways is a hypothesis for research, not proof that a combination is beneficial or safe. None of the intervention studies summarized here establishes a personal combination protocol.
Do oral glutathione results establish the effects of an injection?
No. A change in route changes the research question. The oral studies cannot validate a different formulation or establish that a catalog vial is suitable for human use. Our study-reading checklist explains how to keep route and formulation attached to a finding.
Review method and source access
Reviewed November 18, 2026: full publisher text of the 2019 NAD+ pilot, full text of the 2011 glutathione trial, and indexed abstracts for the 2015 glutathione trial and the 2026 blood-metabolite study. On November 19, 2026, the 2019 pilot safety passage and the indexed abstracts of the 2011, 2015 and 2026 studies were rechecked for the selected findings above. The full 2011 paper was not re-accessed during that recheck. Abstract-only access does not permit complete evaluation of methods or adverse-event tables. This selected-source narrative review is not a systematic review or independent clinical assessment. It supplies no personal-use recommendation.
Where does NAC fit in this comparison?
N-acetylcysteine (NAC), glutathione and NAD+ are different molecules. NAC can contribute to glutathione synthesis indirectly; a change in one measurement does not establish that the materials have equivalent effects. Read NAD+ vs NAC for the separate identities and study limits.
References
These are the sources discussed above. Access scope and review limits are stated in the review-method section.
